id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-D-2922-0002,FDA,FDA-2022-D-2922,"Compounding Certain Beta-Lactam Products in Shortage Under Section 503A of the Federal Food, Drug, and Cosmetic Act
Immediately in Effect Guidance for Industry",Other,Guidance,2022-11-23T05:00:00Z,2022,11,2022-11-23T05:00:00Z,,2024-11-07T00:44:33Z,,1,0,09000064854ff946
FDA-2022-D-2922-0001,FDA,FDA-2022-D-2922,"Compounding Certain Beta-Lactam Products in Shortage Under Section
503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry;
Availability",Notice,Guidance,2022-11-23T05:00:00Z,2022,11,2022-11-23T05:00:00Z,,2022-11-23T14:38:36Z,2022-25622,0,0,09000064854fe37a